Reliable results in 15 minutes to facilitate timely disease management decisions
When your patients present with a fever, cough, and other common respiratory symptoms, choosing the appropriate treatment requires determining the cause of their illness. The CLINITEST® Rapid COVID-19 + Influenza Antigen Test, distributed by Siemens Healthineers, enables you to detect and differentiate infections involving any combination of these three respiratory viruses at the point of care.
Clinical Performance
![COVID-19 Use Case](https://marketing.webassets.siemens-healthineers.com/28ebb23a7ccc1b1c/efe077bd565e/v/ea1fae248015/siemens-healthineers-digital_solutions-ehealth_virtual_visit-COVID-19-Use-Case.png)
Monitoring Variants of Concern
Omicron Update
Siemens Healthineers is committed to monitoring all current and emerging variants of concern (VOCs) by directly testing with clinical samples and using a computer-based inspection tool called in silico analysis. The Omicron variant (B.1.1.529) is recognized by the WHO, CDC, and ECDC as a VOC. Siemens Healthineers internal data demonstrate that the CLINITEST® Rapid COVID-19 Antigen (Self) Test detects SARS-CoV-2 virus/coronavirus infection of the Omicron variant and its major sub-variants, including BA.1, BA.2, BA.2.75, BA.3, BA.4, BA.4.6, BA.5, BF.7, and XE.